| Year |
Citation |
Score |
| 2018 |
Reiman JM, Kumar S, Rodriguez IB, Gnidehou S, Ito K, Stanisic DI, Lee M, McPhun V, Majam V, Willemsen NM, Batzloff MR, Raja AI, Dooley B, Hoffman SL, Yanow SK, et al. Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulation. Clinical & Translational Immunology. 7: e1015. PMID 29670745 DOI: 10.1002/Cti2.1015 |
0.419 |
|
| 2016 |
Giddam AK, Reiman JM, Zaman M, Skwarczynski M, Toth I, Good MF. A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria. Acta Biomaterialia. PMID 27544810 DOI: 10.1016/J.Actbio.2016.08.020 |
0.38 |
|
| 2016 |
Raja AI, Cai Y, Reiman JM, Groves P, Chakravarty S, McPhun V, Doolan DL, Cockburn I, Hoffman SL, Stanisic DI, Good MF. Chemically attenuated blood-stage Plasmodium yoelii parasites induce long-lived and strain-transcending protection. Infection and Immunity. PMID 27245410 DOI: 10.1128/Iai.00157-16 |
0.425 |
|
| 2015 |
Liu TY, Hussein WM, Giddam AK, Jia Z, Reiman JM, Zaman M, McMillan NA, Good MF, Monteiro MJ, Toth I, Skwarczynski M. Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine. Journal of Medicinal Chemistry. 58: 888-96. PMID 25489968 DOI: 10.1021/Jm501514H |
0.484 |
|
| 2014 |
Zaman M, Chandrudu S, Giddam AK, Reiman J, Skwarczynski M, McPhun V, Moyle PM, Batzloff MR, Good MF, Toth I. Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity. Nanomedicine (London, England). 9: 2613-24. PMID 25529566 DOI: 10.2217/Nnm.14.190 |
0.348 |
|
| 2013 |
Good MF, Reiman JM, Rodriguez IB, Ito K, Yanow SK, El-Deeb IM, Batzloff MR, Stanisic DI, Engwerda C, Spithill T, Hoffman SL, Lee M, McPhun V. Cross-species malaria immunity induced by chemically attenuated parasites. The Journal of Clinical Investigation. PMID 23863622 DOI: 10.1172/Jci66634 |
0.414 |
|
| 2010 |
Reiman JM, Knutson KL, Radisky DC. Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells Cancer Research. 70: 3005-3008. PMID 20395197 DOI: 10.1158/0008-5472.Can-09-4041 |
0.625 |
|
| 2009 |
Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S, Knutson KL. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Research. 69: 2887-95. PMID 19276366 DOI: 10.1158/0008-5472.Can-08-3343 |
0.591 |
|
| 2007 |
Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Tumor immunoediting and immunosculpting pathways to cancer progression Seminars in Cancer Biology. 17: 275-287. PMID 17662614 DOI: 10.1016/J.Semcancer.2007.06.009 |
0.602 |
|
| 2006 |
Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, Disis ML. Immunoediting of cancers may lead to epithelial to mesenchymal transition. Journal of Immunology (Baltimore, Md. : 1950). 177: 1526-33. PMID 16849459 DOI: 10.4049/Jimmunol.177.3.1526 |
0.616 |
|
| Show low-probability matches. |